Endovascular Exclusion of Thoracoabdominal and/or Paravisceral Abdominal Aortic Aneurysm
Key facts
- Where
- San Francisco, United StatesSee the 2 sites
Where in United States
- Division of Vascular Surgery, SFVAMCSan Francisco, United StatesContact: Warren J Gasper, MD (principal investigator)Taking people
- Division of Vascular Surgery, UCSFSan Francisco, United StatesContact: Linda M Reilly, MD (sub-investigator)Taking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorTrial details
- Who runs it
- Warren J. Gasper, MD
- Trial code
- NCT00483249
- Record updated
- 10 November 2026
- Original description
This is a study to assess the safety and effectiveness of endovascular treatment of thoracoabdominal (TAAA) and paravisceral abdominal (PVAAA) aortic aneurysms. The investigational operation involves placing a stent-graft over the aortic aneurysm.Read full original descriptionShow less
This is a study to assess the safety and effectiveness of endovascular treatment of thoracoabdominal (TAAA) and paravisceral abdominal (PVAAA) aortic aneurysms. The investigational operation involves placing a stent-graft over the aortic aneurysm.
Inclusion: Aortic aneurysms:; greater than or equal to 6 cm in diameter in men,; greater than or equal to 5.5 cm in diameter in women,; and/or larger than 5 cm in diameter and enlarging at a rate of more than 5 mm/year,; and/or iliac aneurysms larger than 4 cm in diameter; Anticipated mortality comparable to published rates with conventional surgical treatment; Life expectancy more than 2 years; Ability to give informed consent; Willingness to comply with follow-up schedule; Suitable arterial anatomy for endovascular repair.
Exclusion: Known allergy to Nitinol, stainless steel, or polyester; Serious systemic or groin infection; Free rupture of the aneurysm; Pregnancy; Unwillingness or inability to comply with the follow up schedule; Uncorrectable coagulopathy.